Literature DB >> 20308837

Progesterone receptor genotype, family history, and spontaneous preterm birth.

Tracy A Manuck1, Heather D Major, Michael W Varner, Rakesh Chettier, Lesa Nelson, M Sean Esplin.   

Abstract

OBJECTIVE: To examine whether women with a personal or family history of preterm birth are more likely to have genetic variation in the human progesterone receptor (hPR).
METHODS: Women with a singleton preterm birth at less than 37 weeks of gestation between 2002 and 2006 were identified from a prospectively collected clinical and biologic obstetric database (cases). Women in the control group were those with only term deliveries at or above 38 weeks of gestation. The Utah Population Database was queried for family history (first- or second-degree relative) of preterm birth. DNA was extracted from stored buffy coats and genotyped for six single nucleotide polymorphisms in the hPR.
RESULTS: One hundred fifty-four patients (92 women in the preterm case group, 62 women in the term control group) were included. All were white or Hispanic. There were no statistical differences between white and Hispanic allele frequencies. Women in the preterm case group were more likely to carry the minor allele, G (minor allele frequency 0.29 compared with 0.18, P=.035) for rs471767, and were more likely to carry the GT haplotype across rs471767 and rs578029 compared with women in the term control group. Similar haplotype block variation was seen among women with preterm birth plus a family history of preterm birth.
CONCLUSION: Allele and haplotype frequencies in the hPR are significantly different among women with preterm birth and women with preterm birth plus a family history of preterm birth. This suggests the hPR gene may be a candidate for association with preterm birth or familial preterm birth. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308837     DOI: 10.1097/AOG.0b013e3181d53b83

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

Review 1.  Genomics of preterm birth.

Authors:  Kayleigh A Swaggart; Mihaela Pavlicev; Louis J Muglia
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

Review 2.  What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.

Authors:  Steve N Caritis; Maisa N Feghali; William A Grobman; Dwight J Rouse
Journal:  Semin Perinatol       Date:  2016-04-19       Impact factor: 3.300

Review 3.  Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2014-09-23       Impact factor: 3.300

4.  Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.

Authors:  Tracy A Manuck; Gregory J Stoddard; Rebecca C Fry; M Sean Esplin; Michael W Varner
Journal:  Am J Obstet Gynecol       Date:  2016-07-11       Impact factor: 8.661

5.  Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.

Authors:  Tracy A Manuck; Yinglei Lai; Paul J Meis; Mitchell P Dombrowski; Baha Sibai; Catherine Y Spong; Dwight J Rouse; Celeste P Durnwald; Steve N Caritis; Ronald J Wapner; Brian M Mercer; Susan M Ramin
Journal:  Am J Obstet Gynecol       Date:  2011-04-08       Impact factor: 8.661

6.  The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.

Authors:  Martha L Bustos; Steve N Caritis; Kathleen A Jablonski; Uma M Reddy; Yoram Sorokin; Tracy Manuck; Michael W Varner; Ronald J Wapner; Jay D Iams; Marshall W Carpenter; Alan M Peaceman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan M Ramin
Journal:  Am J Obstet Gynecol       Date:  2017-05-15       Impact factor: 8.661

7.  Cluster analysis of spontaneous preterm birth phenotypes identifies potential associations among preterm birth mechanisms.

Authors:  M Sean Esplin; Tracy A Manuck; Michael W Varner; Bryce Christensen; Joseph Biggio; Radek Bukowski; Samuel Parry; Heping Zhang; Hao Huang; William Andrews; George Saade; Yoel Sadovsky; Uma M Reddy; John Ilekis
Journal:  Am J Obstet Gynecol       Date:  2015-06-09       Impact factor: 8.661

Review 8.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

9.  Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Authors:  Tracy A Manuck; W Scott Watkins; Barry Moore; M Sean Esplin; Michael W Varner; G Marc Jackson; Mark Yandell; Lynn Jorde
Journal:  Am J Obstet Gynecol       Date:  2014-03-01       Impact factor: 8.661

10.  Natural Selection Has Differentiated the Progesterone Receptor among Human Populations.

Authors:  Jingjing Li; Xiumei Hong; Sam Mesiano; Louis J Muglia; Xiaobin Wang; Michael Snyder; David K Stevenson; Gary M Shaw
Journal:  Am J Hum Genet       Date:  2018-06-21       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.